Elizabeth L. Hougen
Net Worth

Last updated:

What is Elizabeth L. Hougen net worth?

The estimated net worth of Ms. Elizabeth L. Hougen is at least $18,550,031 as of 2 Feb 2024. She owns shares worth $3,946,604 as insider, has earned $4,257,867 from insider trading and has received compensation worth at least $10,345,560 in Ionis Pharmaceuticals, Inc..

What is the salary of Elizabeth L. Hougen?

Ms. Elizabeth L. Hougen salary is $862,130 per year as Executive Vice President & Chief Financial Officer in Ionis Pharmaceuticals, Inc..

How old is Elizabeth L. Hougen?

Ms. Elizabeth L. Hougen is 63 years old, born in 1962.

What stocks does Elizabeth L. Hougen currently own?

As insider, Ms. Elizabeth L. Hougen owns shares in one company:

Company Title Shares Price per share Total value
Ionis Pharmaceuticals, Inc. (IONS) Executive Vice President & Chief Financial Officer 92,905 $42.48 $3,946,604

What does Ionis Pharmaceuticals, Inc. do?

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of TTR amyloidosis; Olezarsen for patients with severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Tofersen to inhibit the production of superoxide dismutase 1. In addition, the company develops medicines for metabolic diseases, infectious diseases, renal diseases, ophthalmic diseases, and cancer. It has a strategic collaboration with Biogen Inc.; and collaboration and license agreement with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.

IONS logo
IONS
Ionis Pharmaceuticals, Inc.
$42.48

Elizabeth L. Hougen insider trading

Ionis Pharmaceuticals, Inc.

Ms. Elizabeth L. Hougen has made 32 insider trades between 2013-2024, according to the Form 4 filled with the SEC. Most recently she sold 2,125 units of IONS stock worth $105,273 on 2 Feb 2024.

The largest trade she's ever made was exercising 45,225 units of IONS stock on 28 Dec 2023. As of 2 Feb 2024 she still owns at least 92,905 units of IONS stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 2,125 $49.54 $105,273
Sale
Common Stock 8,683 $50.42 $437,771
Option
Common Stock 22,487 N/A N/A
Option
Restricted Stock Unit 22,487 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 45,225 $47.34 $2,140,952
Option
Common Stock 45,225 $47.34 $2,140,952
Sale
Common Stock 2,079 $40.59 $84,393
Sale
Common Stock 8,280 $39.7 $328,724
Option
Common Stock 23,154 N/A N/A
Option
Restricted Stock Unit 23,154 N/A N/A
Option
Restricted Stock Unit 22,050 N/A N/A
Option
Common Stock 22,050 N/A N/A
Option
Common Stock 17,151 N/A N/A
Option
Restricted Stock Units 17,151 N/A N/A
Option
Common Stock 21,680 $39.87 $864,382
Sale
Common Stock 21,680 $39.87 $864,382
Option
Non-Qualified Stock Option (right to buy) 21,680 $39.87 $864,382
Sale
Common Stock 4,320 $50.83 $219,586
Option
Common Stock 4,320 $50.83 $219,586
Option
Non-Qualified Stock Option (right to buy) 4,320 $50.83 $219,586
Option
Common Stock 19,000 $44.99 $854,810
Option
Non-Qualified Stock Option (right to buy) 19,000 $44.99 $854,810
Sale
Common Stock 13,125 $39.87 $523,294
Option
Restricted Stock Units 12,044 N/A N/A
Option
Common Stock 12,044 N/A N/A
Option
Common Stock 10,634 $10.82 $115,060
Option
Employee Stock Option (right to buy) 7,196 $10.82 $77,861
Option
Employee Stock Option (right to buy) 4,566 $37.91 $173,097
Sale
Common Stock 504 $10.82 $5,453
Option
Common Stock 4,566 $37.91 $173,097
Option
Common Stock 4,000 $10.82 $43,280
Option
Employee Stock Option (right to buy) 4,000 $10.82 $43,280
Sale
Common Stock 4,000 $10.82 $43,280
Option
Employee Stock Option (right to buy) 4,000 $10.82 $43,280
Option
Common Stock 4,000 $10.82 $43,280
Sale
Common Stock 4,000 $10.82 $43,280
Option
Restricted Stock Units 7,891 N/A N/A
Option
Common Stock 7,891 N/A N/A
Sale
Common Stock 2,063 $52.05 $107,379
Option
Common Stock 2,063 $52.05 $107,379
Option
Employee Stock Option (right to buy) 2,063 $52.05 $107,379
Sale
Common Stock 2,000 $7.25 $14,500
Option
Common Stock 2,000 $7.25 $14,500
Option
Employee Stock Option (right to buy) 2,000 $7.25 $14,500
Sale
Common Stock 2,724 $51.76 $140,994
Option
Restricted Stock Units 6,732 N/A N/A
Option
Common Stock 6,732 N/A N/A
Sale
Common Stock 5,000 $10.29 $51,450
Option
Employee Stock Option (right to buy) 5,000 $10.29 $51,450
Option
Common Stock 5,000 $10.29 $51,450
Sale
Common Stock 4,000 N/A N/A
Option
Common Stock 4,000 N/A N/A
Option
Employee Stock Option (right to buy) 4,000 N/A N/A
Option
Common Stock 6,000 $10.29 $61,740
Sale
Common Stock 6,000 $10.29 $61,740
Option
Employee Stock Option (right to buy) 6,000 $10.29 $61,740
Option
Employee Stock Option (right to buy) 7,000 $10.29 $72,030
Option
Common Stock 7,000 $10.29 $72,030
Sale
Common Stock 7,000 $10.29 $72,030
Sale
Common Stock 2,273 $46.29 $105,219
Option
Restricted Stock Units 5,161 N/A N/A
Option
Common Stock 5,814 N/A N/A
Option
Common Stock 2,500 $11.27 $28,175
Sale
Common Stock 2,500 $11.27 $28,175
Option
Employee Stock Option (right to buy) 2,500 $11.27 $28,175
Option
Common Stock 2,500 $11.27 $28,175
Sale
Common Stock 2,500 $11.27 $28,175
Option
Employee Stock Option (right to buy) 2,500 $11.27 $28,175
Sale
Common Stock 2,500 $11.27 $28,175
Option
Common Stock 2,500 $11.27 $28,175
Option
Employee Stock Option (right to buy) 2,500 $11.27 $28,175
Option
Common Stock 2,500 $11.27 $28,175
Sale
Common Stock 2,500 $11.27 $28,175
Option
Employee Stock Option (right to buy) 2,500 $11.27 $28,175
Sale
Common Stock 1,899 $41.46 $78,740
Option
Restricted Stock Units 2,887 N/A N/A
Option
Common Stock 4,762 N/A N/A
Option
Restricted Stock Unit 1,875 N/A N/A
Sale
Common Stock 10,000 $11.27 $112,700
Option
Common Stock 10,000 $11.27 $112,700
Option
Employee Stock Option (right to buy) 10,000 $11.27 $112,700
Option
Common Stock 28,094 $52.49 $1,474,514
Sale
Common Stock 12,657 $14.47 $183,147
Option
Employee Stock Option (right to buy) 28,094 $7.24 $203,260
Sale
Common Stock 1,291 $67.96 $87,742
Option
Restricted Stock Units 3,383 N/A N/A
Option
Common Stock 3,383 N/A N/A
Sale
Common Stock 577 $47.08 $27,165
Option
Restricted Stock Units 1,509 N/A N/A
Option
Common Stock 1,509 N/A N/A
Sale
Common Stock 10,417 $15.38 $160,213
Option
Common Stock 10,417 $15.38 $160,213
Option
Employee Stock Option (right to buy) 10,417 $15.38 $160,213
Sale
Common Stock 9,843 $14.47 $142,428
Option
Employee Stock Option (right to buy) 17,656 $7.24 $127,741
Option
Common Stock 17,656 $19.68 $347,435
Option
Employee Stock Option (right to buy) 9,584 $11.12 $106,574
Option
Common Stock 14,376 $14.63 $210,249
Sale
Common Stock 9,584 $11.12 $106,574
Sale
Common Stock 5,040 $6.81 $34,322
Option
Common Stock 5,040 $6.81 $34,322
Option
Employee Stock Option (right to buy) 5,040 $6.81 $34,322
Sale
Common Stock 242 $14 $3,388
Option
Common Stock 542 N/A N/A
Option
Restricted Stock Units 542 N/A N/A